Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT5A | hg38_v1_chr17_+_42288076_42288172 | 0.24 | 1.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_50611767 Show fit | 7.53 |
ENST00000443053.6
ENST00000348721.4 |
cytokine inducible SH2 containing protein |
|
chr3_+_111542178 Show fit | 5.16 |
ENST00000283285.10
ENST00000352690.9 |
CD96 molecule |
|
chr3_+_50611871 Show fit | 4.37 |
ENST00000446044.5
|
MAPK activated protein kinase 3 |
|
chr1_-_157700738 Show fit | 4.25 |
ENST00000368186.9
ENST00000496769.1 ENST00000368184.8 |
Fc receptor like 3 |
|
chr3_+_111542134 Show fit | 4.19 |
ENST00000438817.6
|
CD96 molecule |
|
chr19_-_51372640 Show fit | 4.03 |
ENST00000600427.5
ENST00000221978.10 |
natural killer cell granule protein 7 |
|
chr8_-_6978634 Show fit | 4.00 |
ENST00000382679.2
|
defensin alpha 1 |
|
chr15_+_58138368 Show fit | 3.94 |
ENST00000219919.9
ENST00000536493.1 |
aquaporin 9 |
|
chr4_+_40192949 Show fit | 3.81 |
ENST00000507851.5
ENST00000615577.4 ENST00000613272.4 |
ras homolog family member H |
|
chr4_-_70666492 Show fit | 3.72 |
ENST00000254801.9
ENST00000391614.7 |
joining chain of multimeric IgA and IgM |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 20.9 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 9.6 | GO:0045576 | mast cell activation(GO:0045576) |
3.1 | 9.3 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.8 | 9.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 8.6 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 7.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.6 | 7.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 7.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.5 | 7.3 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 7.0 | GO:0018377 | protein myristoylation(GO:0018377) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 39.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 18.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 16.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 14.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 14.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
2.3 | 9.2 | GO:0071757 | hexameric IgM immunoglobulin complex(GO:0071757) |
0.7 | 8.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 8.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 7.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 6.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 24.8 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 11.4 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 10.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
1.3 | 9.2 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 8.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 8.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 7.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 7.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 7.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 7.1 | GO:0019902 | phosphatase binding(GO:0019902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 19.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 16.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 15.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 14.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 11.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 8.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 7.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 7.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 6.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 6.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 36.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 17.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 13.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 11.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 9.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 9.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 8.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 8.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 8.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 7.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |